The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
No Access

Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients

Published Online:https://doi.org/10.1176/ajp.139.6.763

In addition to its ability to decrease plasma cortisol levels, dexamethasone can also significantly decrease plasma prolactin levels. In 52 psychiatric patients, including 26 patients with primary major depression or schizoaffective depression, primarily affective type, there was a significant association between nonsuppression of plasma cortisol and prolactin after administration of dexamethasone. These results suggest that the abnormal cortisol response to dexamethasone in some psychiatric patients may be due to a pituitary gland abnormality rather than to a limbic system abnormality. The sensitivity and specificity of the dexamethasone suppression test for endogenous depression were less than previously reported.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.